The RNA polymerase gene of human coronavirus (HCV) 229E encodes a larg
e polyprotein that contains domains with motifs characteristic of both
papain-like cysteine proteinases and proteinases with homology to the
3C proteinase of picornaviruses. In this study, we have, first, expre
ssed the putative HCV 229E 3C-like proteinase domain as part of a beta
-galactosidase fusion protein in Escherichia coli and have shown that
the expressed protein has proteolytic activity. The substitution of on
e amino acid within the predicted proteinase domain (His-3006-->Asp-30
06) abolishes, or at least significantly reduces, this activity. Amino
-terminal sequence analysis of a purified, 34-kDa cleavage product sho
ws that the bacterial fusion protein is cleaved at the dipeptide Gln-2
965-Ala-2966, which is the predicted amino-terminal end of the putativ
e 3C-like proteinase domain, Second, we have confirmed the proteolytic
activity of a bacterially expressed polypeptide with the amino acid s
equence of the predicted HCV 229E 3C-like proteinase by trans cleavage
of an in vitro translated polypeptide encoded within open reading fra
me 1b of the RNA polymerase gene. Finally, using fusion protein-specif
ic antiserum, we have identified a 34-kDa, 3C-like proteinase polypept
ide in HCV 229E-infected MRC-5 cells, This polypeptide can be detected
as early as 3 to 5 h postinfection but is present in the infected cel
l in very low amounts. These data contribute to the characterization o
f the 3C-like proteinase activity of HCV 229E.